iStat Biomedical Co., Ltd. - Epigene

iStat, Epigene, Epigenebio, Cervical cancer test, Oral cancer test, Cancer methylation test, Epigenetic IVD assay, Non-invasive early cancer detection, DNA Methylatoin, 日祥, 甲基化基因檢測, 癌症基因檢測

iStat- Epigenetic IVD assay for cancer DNA methylation biomarkers. iStat is a Taiwan-based biotechnology company specialized in the development and manufacturing of high quality gene methylation assay products for the early detection of cervical, oral, and bladder cancers. The company provides innovative IVD products for use in the clinical laboratories and solutions for medication managements. The company is actively seeking distributors in Europe, Middle East, and Latin America, and is discussing licensing potentials with some of the global companies.

Latest News - #Events

iStat Biomedical attended CSCCP 2017 in China

          iStat Biomedical Co., Ltd. attended Chinese Society for Colposcopy and Cervical Pathology (CSCCP) 2017 Conference in Beijing, China, from May 19th to 21th, which is the largest conference on gynecology and gynecologic oncology in China. This conference is dedic ...

iStat Biomedical to exhibit at Biomedica 2017

iStat Biomedical Co., Ltd. is excited to announce that we are going to exhibit at Biomedica Summit in TU Eindhoven, Eindhoven, Netherland from May 9th to 10th, in which several of our diagnostic assay products will be showcased, including Epigene® DNA Methylation assays and Epigene® Sample P ...

iStat Biomedical to exhibit at TAOMS 2017

iStat Biomedical to exhibit at TAOMS 2017       iStat Biomedical Co., Ltd. (“iStat”) will formally present a couple of the company's oral cancer early detection products, Epigene® DNA Methylation assays and Epigene® Sample Preparation system, at the Tai ...

iStat Biomedical Co., Ltd. To Exhibit MEDLAB 2017

iStat Biomedical Co., Ltd. To Exhibit MEDLAB 2017, the World's largest Laboratory Exhibition.        iStat Biomedical Co., Ltd. is excited to announce that we are going to exhibit at MedLab 2017 in Dubai from February 6th to 9th. Our booth will be located at Za’abeel ...

Attend the 2014 AACC Clinical Lab Expo.

iStat Biomedical Co. Ltd will attend the 2014 AACC (American Association for Clinical Chemistry) Clinical Lab Expo. We invite you to see us at the 2014 American Association for Clinical Chemistry (AACC) Clinical Lab Expo (Booth#3341) from 29th to 31st July, 2014, at Chicago, USA. iStat Biomedical ...

AOGIN 2012 7/14-7/15/2012

iStat at the AOGIN 2012 Annual Meeting and Exhibition 7/14-7/15/2012   Related Speech Information: 7/14 11:40-12:00 Section3: HPV and host gene methylation in cervical cancer detection  Speaker: Dr. Lai Hung Cheng 7/14 16:30  Section10:Methylation bio-markers for screening an ...
iStat- Epigenetic IVD assay for cancer DNA methylation biomarkers. iStat is a Taiwan-based biotechnology company specialized in the development and manufacturing of high quality gene methylation assay products for the early detection of cervical, oral, and bladder cancers. The company provides innovative IVD products for use in the clinical laboratories and solutions for medication managements. The company is actively seeking distributors in Europe, Middle East, and Latin America, and is discussing licensing potentials with some of the global companies.
en